Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Hiroki Kobayashi, Ryota Chijimatsu, Yusuke Naoi, Joji Ishida, Hiroyuki Murakami, Kazuhiro Ikeuchi, Tomohiro Urata, Keisuke Seike, Hideaki Fujiwara, Nobuharu Fujii, Ken-ichi Matsuoka, Yasuharu Sato, Daisuke Ennishi
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma
10.1093/neuonc/noy192 · 2019
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
10.1182/blood.2020008520 · 2021
Molecular subtypes and genomic profile of primary central nervous system lymphoma
10.1093/jnen/nlz125 · 2020
Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome
10.1084/jem.20200483 · 2020
Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels
10.1038/s41556-020-0532-x · 2020
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma
10.1016/j.ccell.2021.08.011 · 2021
Single-cell transcriptome analysis of diffuse large B cells in cerebrospinal fluid of central nervous system lymphoma
10.1016/j.isci.2021.102972 · 2021
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma
10.1186/s13073-022-01110-1 · 2022
Single-cell landscape of primary central nervous system diffuse large B-cell lymphoma
10.1038/s41421-023-00559-7 · 2023
Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma
10.1182/blood-2011-07-363820 · 2012
Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma
10.1200/jco.18.01583 · 2019
Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition
10.1158/2159-8290.cd-18-1090 · 2019
Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart
10.1111/his.12706 · 2015
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas
10.1111/j.1365-2141.2007.06661.x · 2007
Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma
10.1093/neuonc/not012 · 2013
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
10.1182/blood-2013-11-536433 · 2014
Genetic and functional drivers of diffuse large B cell lymphoma
10.1016/j.cell.2017.09.027 · 2017
A single-cell atlas of diffuse large B cell lymphoma
10.1016/j.celrep.2022.110713 · 2022
The DisGeNET cytoscape app: exploring and visualizing disease genomics data
10.1016/j.csbj.2021.05.015 · 2021
Prognostic significance of HLA class I and II expression in patients with diffuse large B cell lymphoma treated with standard chemoimmunotherapy
10.1007/s00262-016-1883-9 · 2016
The genomic and transcriptional landscape of primary central nervous system lymphoma
10.1038/s41467-022-30050-y · 2022
The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling
10.7150/thno.54343 · 2021
Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphoma
10.1093/neuonc/noy019 · 2018
Lymphomas with plasmablastic features: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology
10.1007/s00428-023-03585-8 · 2023
CD38 positively regulates postnatal development of astrocytes cell-autonomously and oligodendrocytes non-cell-autonomously
10.1002/glia.23139 · 2017
Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages
10.1038/s41467-021-21407-w · 2021
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
10.1038/nature08638 · 2010
Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma
10.1016/j.ccr.2010.11.024 · 2010
Spatial single cell analysis of tumor microenvironment remodeling pattern in primary central nervous system lymphoma
10.1038/s41375-023-01908-x · 2023
M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma
10.3960/jslrt.51.93 · 2011
Tumor-associated macrophages associate with cerebrospinal fluid interleukin-10 and survival in primary central nervous system lymphoma (PCNSL)
10.1111/bpa.12318 · 2016
The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma
10.1007/s00277-017-3014-x · 2017
Intratumor heterogeneity: the Rosetta stone of therapy resistance
10.1016/j.ccell.2020.03.007 · 2020
A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling
10.1038/s41556-022-00866-3 · 2022
Pathway analysis of primary central nervous system lymphoma
10.1182/blood-2007-10-119099 · 2008
No additional external references are available.